Antimicrobial activity of the new FabI inhibitor afabicin desphosphono against intraosteoblastic Staphylococcus aureus.

Int J Antimicrob Agents

CIRI - Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Lyon, France; Laboratoire de Bactériologie, Institut des Agents Infectieux, Hospices Civils de Lyon, France; Centre Interrégional de Référence des Infections Ostéo-Articulaires complexes (CRIOAc Lyon), Hospices Civils de Lyon, Lyon, France.

Published: May 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijantimicag.2021.106321DOI Listing

Publication Analysis

Top Keywords

antimicrobial activity
4
activity fabi
4
fabi inhibitor
4
inhibitor afabicin
4
afabicin desphosphono
4
desphosphono intraosteoblastic
4
intraosteoblastic staphylococcus
4
staphylococcus aureus
4
antimicrobial
1
fabi
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!